Reports and Testimonies - Browse by topic

Browse By:
  
All Topics » Health Care » Program evaluation » Cost analysis
Sort by Results per page Search within "Cost analysis"

Cost analysis (21 - 30 of 50 items)

End-Stage Renal Disease

Medicare Should Pay a Bundled Rate for All ESRD Items and Services
GAO-07-1050T, Jun 26, 2007

Federal Employees Health Benefits Program

Premiums Continue to Rise, but Rate of Growth Has Recently Slowed
GAO-07-873T, May 18, 2007

National Institutes of Health Extramural Research Grants

Oversight of Cost Reimbursements to Universities
GAO-07-294R, Jan 31, 2007

Federal Employees Health Benefits Program

Premium Growth Has Recently Slowed, and Varies among Participating Plans
GAO-07-141, Dec 22, 2006

Medicaid Outpatient Drugs

Estimated 2007 Federal Upper Limits for Reimbursement Compared with Retail Pharmacy Acquisition Costs
GAO-07-239R, Dec 22, 2006

End-Stage Renal Disease

Bundling Medicare's Payment for Drugs with Payment for All ESRD Services Would Promote Efficiency and Clinical Flexibility
GAO-07-77, Nov 13, 2006

End-Stage Renal Disease

Medicare Payments for All ESRD Services, Including Injectable Drugs, Should Be Bundled
GAO-07-266T, Dec 6, 2006

Medicare Physician Payments

Considerations for Reforming the Sustainable Growth Rate System
GAO-05-326T, Feb 10, 2005

Milwaukee Health Care Spending Compared to Other Metropolitan Areas

Geographic Variation in Spending for Enrollees in the Federal Employees Health Benefits Program
GAO-04-1000R, Aug 18, 2004

Medicare Home Health

Payments to Most Freestanding Home Health Agencies More Than Cover Their Costs
GAO-04-359, Feb 27, 2004
< Prev12345Next >